Form 4: BioLife Solutions Officer Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions, sold 408 shares of common stock on May 29, 2024, at a price of $21.78 per share.

Summary

  • Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions Inc. (BLFS), reported a transaction involving the sale of company stock.
  • On May 29, 2024, Foster sold 408 shares of common stock at a price of $21.78 per share.
  • The sale was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022, to cover tax withholding obligations related to the vesting of restricted stock.
  • Following the transaction, Foster directly owns 158,171 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an officer to cover tax obligations. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company officers are a normal part of corporate governance. The sale was executed under a pre-arranged trading plan, which is a common practice to avoid accusations of insider trading.

Stakeholder Impact

  • The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact as it was pre-planned and for tax purposes.

Key Dates

DateDescription
02/24/2022Date of adoption of Rule 10b5-1(c) trading plan
05/29/2024Date of stock sale transaction
05/31/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.